SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Josh C. Pleasure, M.D. who wrote ()2/6/1997 6:37:00 PM
From: Josh C. Pleasure, M.D.   of 371
 
Here's a copy of a post from AOL that is a copy of a post from Prodigy. I have heard nothing about this. Can anyone verify?

Would like some input on this stock. It is my understanding
that Kaiser Permente (a large hospital chain) on the west
coast has contracted to use CEA-Scan exclusively concerning
the diagnosis of colo-rectal cancer. They made this decision
based on accuracy and cost efficiency. CEA-Scan will also be
featured in a cancer symposium hosted by the Society of
Surgical Oncologists in Chicago, March 20-23. The big
question remains, what is Lehman Bros. doing? Were they not
brought in to help market this product and show through
statistical projections how Immunomedics will grow at a
souring pace? I do not mean to sound down on this stock as I
think it is still a very good investment, but someone in
that organization really needs to stimulate the marketing
effort. All comments welcome!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News